ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Mortality"

  • Abstract Number: 0149 • ACR Convergence 2025

    Effect Of Osteoporosis And Opioid Use On Mortality And Unplanned Healthcare Utilization Among Patients With Rheumatoid Arthritis

    Viengneesee Thao, Molly Moore Jeffery, Nafisseh Warner and Elena myasoedova, Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis (RA) have a 2-fold increase in risk for osteoporosis compared to the general population. About 30-50% of RA patients experience…
  • Abstract Number: 1906 • ACR Convergence 2025

    The incidence and mortality of connective tissue diseases in England: a population-level cohort study from 2012 to 2023

    Samir Patel1, Mark Russell1, Katie Bechman1, Maryam Adas1, Zijing Yang1, Edward Alveyn1, Chris Wincup2, Alexandru Dregan1, Kate Bramham1, Sam Norton1, James Galloway1 and Patrick Gordon1, 1King's College London, London, United Kingdom, 2King's College Hospital, London, United Kingdom

    Background/Purpose: The reported incidence and mortality of connective tissue diseases (CTDs) in England has been inconsistent in the literature. Our objective was to describe current…
  • Abstract Number: 1420 • ACR Convergence 2025

    A Nationwide Analysis of In-Hospital Mortality in Adult Ankylosing Spondylitis

    Isadora Small1, Anuya Natu2 and Augustine Manadan3, 1The Latin School of Chicago, Chicago, IL, 2John H Stroger, Jr. Hospital of Cook County, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory disease with systemic complications that may contribute to increased mortality risk. This study examines the characteristics and…
  • Abstract Number: 0633 • ACR Convergence 2025

    Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis (AAV) and Systemic Lupus Erythematosus (SLE): A Comparative Analysis

    Sai Shanmukha Sreeram Pannala1, Medha Rajamanuri2, Srikar Sama3, Fares Saliba4, Omar Mourad5, Elizabeth Fagin6, Koushik Varma Sangaraju7, Veena Katikineni8 and Anastasia Slobodnick9, 1Northwell health/Staten Island university Hospital, new york city, NY, 2Southern Illinois University School of Medicine, Springfield, IL, 3University of California San Francisco Fresno, Fresno, CA, 4Staten Island University Hospital, Staten Island, NY, 5Zucker School of Medicine at Hofstra/Northwell at Staten Island University Hospital, Staten Island, NY, 6Staten Island University Hospital, Teaneck, NJ, 7St. Luke's University Health Network, Bethlehem, PA, 8Desert Orthopaedic and Rheumatologic Institute, Apple Valley, CA, 9Northwell, Staten Island, NY

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a rare but severe complication in Systemic Lupus Erythematosus (SLE), occurring in up to one-third of cases at disease…
  • Abstract Number: 0146 • ACR Convergence 2025

    Association between frailty and delirium and hospitalization outcomes among older adults with rheumatic diseases

    Bhavik Bansal1, Yehseo Jung2, Abdulla Damluji3, Parag Goyal4 and Namrata Singh5, 1UT Southwestern Medical Centre, Dallas, TX, 2University of Washington, Seattle, WA, 3Johns Hopkins, Baltimore, 4Weill Cornell, New York, 5University of Washington, Bellevue, WA

    Background/Purpose: We investigated the association of frailty and delirium, both independently and in combination, with in-hospital mortality and non-routine discharge (i.e. when a patient is…
  • Abstract Number: 0685 • ACR Convergence 2024

    KL-6 and IL-18 Biomarkers in Systemic Sclerosis-associated Interstitial Lung Disease: Enhancing Prognostic Insights into Early Detection, Progression, Lung Volume Changes,and Mortality Risk

    cristiana sieiro santos1, Miriam Retuerto2, Laura Sierra2, Sara Calleja Antolín2, Elena Bollo de Miguel2, Jose Ordas Martínez3, Paula Pérez García2, Pedro Baenas2, Clara Moriano Morales2, Javier de la Calle Lorenzo2 and Elvira Díez Álvarez4, 1Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain, 2Complejo Asistencial Universitario de León, León, Spain, 3Complejo Asistencial Universitario de Leon, Leon, 4Complejo Asistencial Universitario de León, Leon, Spain

    Background/Purpose: Interstitial lung disease (ILD) is a leading cause of mortality in scleroderma, underscoring the critical demand for reliable biomarkers. KL-6 and IL-18, have been…
  • Abstract Number: 1327 • ACR Convergence 2024

    Association of Rheumatoid Arthritis and Frailty Status with Mortality in Patients with Renal Cell Carcinoma

    Sherwin Novin1, Sarah Holt2, Maya Swaminathan3, Jonathan Wright2, John Gore2, Kimme Hyrich4, Sizheng Zhao5, Jeffrey Sparks6, Una Makris7, Maria Suarez-Almazor8, Petros Grivas2, Sarah Psutka2 and Namrata Singh9, 1University of Washington, Seattle, WA, 2University of Washington, Seattle, 3MultiCare, Newcastle, WA, 4Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom, 5Centre for Musculoskeletal Research, The University of Manchester, Liverpool, United Kingdom, 6Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 7UT Southwestern Medical Center and Dallas VA, Dallas, TX, 8MD Anderson Cancer Center, Houston, TX, 9University of Washington, Bellevue, WA

    Background/Purpose: Few studies have evaluated clinical outcomes and prognosis of patients with cancer with and without rheumatoid arthritis (RA). Renal cell carcinoma (RCC) is particularly…
  • Abstract Number: 2241 • ACR Convergence 2024

    Associations Between Disease Activity, Physical Function and Anti-rheumatic Medications with All-cause Mortality in Rheumatoid Arthritis (RA): Data from a Canadian RA Registry

    Mohammad Movahedi1, Angela Cesta2, Xiuying Li2, Bindee Kuriya3, Sibel Aydin4, Ed Keystone5, Janet Pope6 and Claire Bombardier7, and OBRI investigators, 1Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 2UHN, Toronto, ON, Canada, 3University of Toronto - Toronto, Toronto, ON, Canada, 4Ottawa Hospital Research Institute, Ottawa, ON, Canada, 5Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 6University of Western Ontario, London, ON, Canada, 7University of Toronto, Toronto, ON, Canada

    Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk of hospitalizations and mortality due to RA itself, associated comorbidities, and treatment-related complications. The purpose…
  • Abstract Number: 0686 • ACR Convergence 2024

    The Role of Inflammation in Systemic Sclerosis: CRP-Associated Phenotypes and Prognostic Implications

    cristiana sieiro santos1, Miriam Retuerto2, Paula Pérez García2, Jose Ordas Martínez3, Pedro Baenas2, Clara Moriano Morales2 and Elvira Díez Álvarez4, 1Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain, 2Complejo Asistencial Universitario de León, León, Spain, 3Complejo Asistencial Universitario de Leon, Leon, 4Complejo Asistencial Universitario de León, Leon, Spain

    Background/Purpose: Systemic sclerosis (SSc) manifests through a diverse interplay of inflammatory, fibrotic, and vascular alterations, intricately entwined in its pathogenesis, which encompasses immune system dysregulation,…
  • Abstract Number: 1400 • ACR Convergence 2024

    Disease Modifying Anti-rheumatic Drug Use and Association with Survival in Patients with Rheumatoid Arthritis and Newly Diagnosed Lung Cancer

    Varun Nandakumar1, Aaron Baraff2, Alexander Peterson2, Nicholas Smith3, Jennifer Barton4, Ann O'Hare2, Christopher Li5, Noel Weiss3 and Namrata Singh6, 1AIIMS, New Delhi, Delhi, India, 2VA PUGET SOUND SEATTLE, Seattle, WA, 3University of Washington, Seattle, WA, 4VA Portland Health Care System/OHSU, Portland, OR, 5University of Washington, Seattle, 6University of Washington, Bellevue, WA

    Background/Purpose: Despite the significant therapeutic benefits of various disease modifying anti-rheumatic drugs (DMARDs) in RA, concerns remain regarding their safety, particularly their potential impact on…
  • Abstract Number: 2250 • ACR Convergence 2024

    Cause Specific Mortality Differs in Rheumatoid Arthritis by Sex and Seropositivity

    Elena Joerns1, Ryan Lennon2, Cynthia Crowson2, Andrea Lopez-ruiz2, Roslin Jose George2, Vanessa Kronzer2, John Davis2 and Elena Myasoedova2, 1Mayo Clinic, Rochester, 2Mayo Clinic, Rochester, MN

    Background/Purpose: Persons with rheumatoid arthritis (RA) have an increased risk of mortality compared to the general population. Seropositivity has been shown to be associated with…
  • Abstract Number: 0689 • ACR Convergence 2024

    Arrhythmic Burden, Myocardial Markers, and Long-term Survival in Distinct Cardiac Magnetic Resonance Subsets of Systemic Sclerosis

    Silvia Laura Bosello1, Enrico De Lorenzis2, Giacomo De Luca3, Antonio Tonutti4, veronica Batani5, Pier Giacomo Cerasuolo6, Gerlando Natalello7, Lucia Lanzo6, Gabriella Alonzi6, Silvia Fiore6, Stefano Di Murro6, Andrea Zoli6, Valentina Boni6, Riccardo Marano8, Francesca Augusta Gabrielli9, Francesco Del Galdo10, Dan Knight11, Vivek Muthurangu11, Christopher Denton12, Maria De Santis4, Marco Matucci Cerinic5 and Maria Antonietta D'Agostino13, 1Unit of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 2Catholic University of the Sacred Heart, Roma, Rome, Italy, 3Vita-Salute San Raffaele University & IRCCS San Raffaele Hospital, Milan, Milan, Italy, 4Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Italy, 5Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 6Division of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 7Division of Rheumatology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Rome, Italy, 8Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Diagnostic Imaging Area, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, 9Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 10University of Leeds, Leeds, United Kingdom, 11UCL Department of Cardiac MRI, University College London (Royal Free Campus), London, United Kingdom, 12University College London, Northwood, United Kingdom, 13Division of Rheumatology, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy

    Background/Purpose: Cardiac involvement in Systemic Sclerosis (SSc) is widely recognized as heterogeneous and, when clinically evident, it is associated with a poor prognosis. Recently, five…
  • Abstract Number: 1522 • ACR Convergence 2024

    Impact of Thrombocytopenia on In-hospital Mortality and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus: An Analysis of the National Inpatient Sample Database 2020

    Soziema Salia1, Ufuoma Mamoh2, Gilava Hedayati2, Joseph Atarere3, Raymond Wadie4, Boniface Mensah3, Joan Morny5 and Indira Acharya6, 1MedStar Union Memorial Hospital, Towson, MD, 2Medstar Union Memorial Hospital, Baltimore, MD, 3Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, MD, 4Department of Internal Medicine, Cayuga Medical Center, Ithaca, NY, 5Piedmont Athens Regional Medical Center, Athens, GA, 6Medstar Internal Medicine Residency Program, Baltimore, MD

    Background/Purpose: Thrombocytopenia is associated with Systemic Lupus Erythematosus (SLE) and occurs at various stages of the disease. It is reported in an estimated 10% to 40% of…
  • Abstract Number: 2297 • ACR Convergence 2024

    Mortality and Its Predictor Variables in Patients with Sjögren Disease: Data from SjögrenSER-Pros Prospective Registry

    Olga Rusinovich1, Zulema Plaza2, Mónica Fernández Castro3, José Rosas-Gómez de Salazar4, Victor Manuel Martinez Taboada5, Alejandro Olive6, Raúl Menor Almagro7, Belen Serrano Benavente8, Judit Font Urgelles9, Angel Garcia-Aparicio10, Sara Manrique-Arija11, Jesus A García-Vadillo12, Ruth Lopez Gonzalez13, Javier Narvaez-García14, Maria Beatriz Rodriguez15, Carlos Galisteo16, Jorge Gonzalez Martin17, Paloma Vela-Casasempere18, Cristina Bohorquez19, MARIA CELIA ERAUSQUIN ARRUABARRENA20, MARIA BEATRIZ PAREDES ROMERO21, ELENA Aurrecoechea22, Sheila Melchor Diaz23, José María Pego-Reigosa24, Sergi Heredia Martin25, Clara Moriano26, Maria Angeles Blazquez Canamero27, Paula Estrada-Alarcón28, enrique Judez29, Joaquin María Belzunegui:30, Consuelo Ramos31, Marta de la Puerta32, Fernando Sánchez-Alonso33 and Jose Luis Andreu34, 1Hospital Universitario Puerta de Hierro Majadahonda., Boadilla del Monte, Spain, 2Fundacion Española de Reumatología, Madrid, Spain, 3Hospital Universitario Puerta de Hierro Majadahonda., Madrid, Madrid, Spain, 4Hospital Marina Baixa, PALMA DE MALLORCA, Comunidad Valenciana, Spain, 5Facultad de Medicina. Universidad de Cantabria, Santander, Cantabria, Spain, 6Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain, 7Department of Rheumatology, Hospital Jerez de la Frontera, Jerez de la Frontera, Spain, 8Hospital Gregorio Marañón, Madrid, Madrid, Spain, 9Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 10Hospital Universitario de Toledo, Toledo, Spain, 11Biomedical Research Institute of Malaga (IBIMA)-Bionand Platform, Department of Rheumatology, Regional University Hospital of Malaga, Malaga, Spain, 12H La Princesa, Madrid, Spain, 13Complejo Hospitalario de Zamora, Zamora, Castilla y Leon, Spain, 14Hospital Universitario de Bellvitge, Barcelona, Spain, 15H Universitario de Canarias, La Laguna- Tenerife, Canarias, Spain, 16Hospital Universitario Parc Taulí, Sabadell, Spain, 17H Madrid Norte SanChinarro, Madrid, Spain, 18Hospital General Universitario Alicante, Alicante, Spain, 19Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Madrid, Spain, 20Gob Canarias, Tenerife, Canarias, Spain, 21H Infanta Sofia, Madrid, Spain, 22HOSPITAL SIERRALLANA, CANTABRIA, Spain, 2312 de Octubre University Hospital, Madrid, Spain, 24Galicia Health Service (SERGAS), Vigo, Spain, 25Hospital de L’Hospitalet, Barcelona, Spain, 26Hospital León, LEON, Spain, 27Hospital Ramon y Cajal, Madrid, Madrid, Spain, 28Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 29H de Albacete, Albacete, Spain, 30H de Donostia, Donostia-San Sebasti, Spain, 31Hospital Universitario Virgen de Valme, Sevilla, Spain, 32Spanish Society of Rheumatology, Madrid, Spain, 33Sociedad Española de Reumatología, Madrid, Spain, 34Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda, Spain

    Background/Purpose: It remains debated if patients with Sjögren´s disease (SjD) have a greater mortality risk. The objective of our study was to determine the magnitude…
  • Abstract Number: 0694 • ACR Convergence 2024

    A Unified Vascular Phenotype Score Identifies Systemic Sclerosis Endotypes and Predicts Prognostic Outcomes: Results from the EUSTAR Database

    Stefano Di Donato1, Michael Hughes2, John Pauling3, Marco Matucci-Cerinic4, Lesley-Anne Bissell5, Edward Jude6, Christopher Denton7, Yannick Allanore8, Marie-Elise Truchetet9 and Francesco Del Galdo10, and EUSTAR collaborators, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK, Leeds, United Kingdom, 2Tameside and Glossop Integrated NHS Foundation Trust & The University of Manchester, Manchester, United Kingdom, 3North Bristol NHS Trust, Bristol, United Kingdom, 4University San Raffaele Milano, Milano, Milan, Italy, 5Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 6Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton-under-Lyne, United Kingdom, 7University College London, Northwood, United Kingdom, 8Université Paris Cité, Paris, France, 9Bordeaux University Hospital, Bordeaux, France, 10University of Leeds, Leeds, United Kingdom

    Background/Purpose: Vascular dysfunction is pivotal in Systemic Sclerosis (SSc) pathogenesis, leading to somatic vascular signs such as pitting scars, Digital Ulcers (DUs), telangiectasia as well…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology